Johnson & Johnson

JNJ · NYSE · USD

$256.03−1.02%−$2.63

Close · October 2, 2026

At a glance

Revenue growth
+6.05%
2025 vs 2024
Net income growth
+90.56%
2025 vs 2024
Net margin
28.5%
2024: 15.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets201,061200,894199,210192,816193,389193,671180,104178,287181,088171,966167,558166,061
Current assets59,77459,17355,62454,61154,49871,55155,89353,24957,81757,00253,49553,703
Cash and equivalents20,42221,68819,70918,23118,57738,47424,10519,98024,87825,47321,85919,728
Short-term investments3363633933313033074173175977451,0683,783
Receivables19,04617,72117,17817,61117,84616,02014,84216,17415,79414,94614,87314,798
Inventory15,14414,58314,19114,14613,41212,65912,44412,60312,16911,38311,18111,198
Net property, plant and equipment23,58223,27024,46922,33821,94920,87121,61820,47919,74819,63220,89818,821
Goodwill48,47948,55848,77248,04848,11744,46844,20044,79944,25036,61636,55836,124
Other intangible assets48,22949,06150,40348,73749,83536,75537,61839,49039,72534,28634,17535,021
Long-term investments1,6351,5911,5751,4521,2761,2585,5241,2771,1435,1939,0694,708
Current liabilities54,89557,71654,12650,86954,18056,90350,32151,75953,93348,72546,28244,370
Accounts payable9,22310,46011,9919,6259,4649,54510,3118,9548,8488,1749,6328,355
Long-term debt37,34437,52739,43839,40839,23538,35530,65131,28931,63625,08225,88126,051
Total debt39,13639,28742,83841,39542,26141,35233,60033,75132,99127,332——
Total liabilities116,090119,708117,666113,539114,916115,562108,614108,129109,550101,94698,78494,833
Total equity (incl. minority)84,97181,18681,54479,27778,47378,10971,49070,15871,53870,02068,77471,228
Retained earnings171,665169,161168,978167,281165,371162,635155,791155,179155,360153,378153,843152,536